• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Cardiovascular complications of chronic rheumatic diseases, An Issue of Rheumatic Disease Clinics of North America

Cardiovascular complications of chronic rheumatic diseases, An Issue of Rheumatic Disease Clinics of North America

9780323849289
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
595.29 zł
506.00 zł Save 89.29 zł
Lowest price within 30 days before promotion: 506.00 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Rheumatic Disease Clinics, guest editors Drs. M. Elaine Husni? and George A. Karpouzas bring their considerable expertise to the topic of Cardiovascular Complications of Chronic Rheumatic Diseases. Top experts in the field cover key topics such as primary and secondary atherosclerotic cardiovascular (ASCVD) risk prevention in the rheumatic disease, pro-thrombotic and pro-atherogenic anti-phospholipid antibodies, recommendations for the use of NSAIDs and CVD risk, and more.
Product Details
Elsevier
93885
9780323849289
9780323849289

Data sheet

Publication date
2022
Issue number
1
Cover
hard cover
Pages count
240
Weight (g)
450
  • Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis
    Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases: An Integrative, Multiparametric Approach
    Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases
    Heart Failure in Rheumatic Disease: Secular Trends and Novel Insights
    Cardiovascular Disease in Large Vessel Vasculitis: Risks, Controversies, and Management Strategies
    Venous Thromboembolism in the Inflammatory Rheumatic Diseases
    Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases
    Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases
    Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis
    Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk: Decades Later, Any New Lessons Learned?
Comments (0)